About this blog

Case Disclosed is a blog written by students, supervising attorneys, directors, alumni, and friends of the Media Freedom & Information Access Clinic.

The views expressed on this blog belong to the author(s) and do not represent the views of Yale Law School or the Media Freedom and Information Access Clinic (MFIA).

[title_1]

On the passing of former NFOIC board president Mal Leary
May 26, 2023
NFOIC Board elects Jeff Roberts of Colorado to presidency
March 1, 2023
NFOIC 2023 Freedom of Information Research Competition Call
February 27, 2023
NFOIC signs on to a legal brief challenging fee waiver denials
December 5, 2022

View more

Tags

Open Records
Free Press
Public Forums
Newsgathering
Internet Infrastructure
Censorship
Mass Surveillance
Information Fiduciaries
International Law
Constitutional Access
Internet Intermediaries
MFIA Docket
Secrecy
Free Expression
Net Neutrality
Social Media
Administrative Law
CRIT
Free Speech
Right to Petition
Government Transparency
Open Data
Privacy and Surveillance
Technology
transparency
reporter's privilege
National Security
Government Accountability
First Amendment Right of Access
Online Speech
First Amendment
FOIA
Fourth Estate
Law Enforcement

Case Disclosed

Supreme Court Avoids Broad Ruling on Free Speech in Credit Card Case

April 1, 2017
By Cortelyou Kenney, Amy Kapczynski

The U.S. Supreme Court ruled that the manner in which a New York law prohibits merchants from imposing credit card surcharges amounts to a regulation of their speech.

Read more

The Risks of Trump's Proposal to Speed Up Drug Approvals

February 20, 2017
By Mark Doré

President Trump has signaled—often and recently—that he believes drug approval moves too slowly. Meeting with drug manufacturers at the White House on Jan. 31, Trump promised quick yes-or-no approval decisions on new drugs (and stressed the need for lower prices and U.S.-based manufacturing).

Read more

Health Canada’s Draft Guidance for Implementing Vanessa’s Law Limits Transparency

January 7, 2017
By Kathleen Choi

Canada’s public health department, Health Canada, is preparing to release its final guidance on the section of Vanessa’s Law designed to promote the transparency of information around pharmaceutical drugs.

Read more